ArticleLaryngoscope investigative otolaryngology2025
Characterizing the Patient Experience of Idiopathic Subglottic Stenosis in Pregnancy.
Article in Laryngoscope investigative otolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterizing the Patient Experience of Idiopathic Subglottic Stenosis in Pregnancy.Laryngoscope investigative otolaryngology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To characterize surgical interventions in pregnancy and postpartum periods and compare them to baseline periods (outside of pregnancy/postpartum) for patients with idiopathic subglottic stenosis (iSGS). Methods: A retrospective chart review was performed for patients undergoing endoscopic treatment for iSGS during pregnancy, postpartum, and baseline periods at The Cleveland Clinic between July 1, 2000 and January 1, 2025. Data collected included disease characteristics, surgery characteristics, and pregnancy history. The primary endpoint was the surgical interval between surgical interventions, defined as the number of days until the following surgical intervention during pregnancy, postpartum, and baseline periods. Results: Nine patients were included in the analysis. Among these patients, there were 17 term deliveries, 1 pre-term delivery, 2 miscarriages, and 2 terminations. There was no statistically significant difference in the surgical interval for patients undergoing surgery during pregnancy when compared to their surgical interval in the one-year postpartum period ( Conclusion: Surgical management of iSGS is safe during pregnancy, and although we observed no significant difference in the surgical interval during pregnancy, postpartum, and baseline periods, four patients did require more surgical interventions after pregnancy, highlighting the importance of counseling patients on the potential risk of iSGS recurrence after pregnancy and closely monitoring these patients during the postpartum period. Level of Evidence: IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.